China Pharma Holdings
CPHI
7 hedge funds and large institutions have $1.17M invested in China Pharma Holdings in 2014 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 4 reducing their positions, and 1 closing their positions.
0% more funds holding
Funds holding: 7 → 7 (0)
0% less ownership
Funds ownership: 0.02% → 0.01% (-0%)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
43% less capital invested
Capital invested by funds: $2.05M → $1.17M (-$879K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 4
Top Buyers
| 1 |
U
UBS
Zurich,
Switzerland
|
+$2.08K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
FWSM
1
First Wilshire Securities Management
Pasadena,
California
| $539K | -$9.15K | -44 | -2% |
|
|
PAM
2
Pope Asset Management
Memphis,
Tennessee
| $461K | -$410K | -1,971 | -46% |
|
|
GA
3
Glenhill Advisors
New York
| $77K | – | – | – |
|
4
Renaissance Technologies
New York
| $56K | -$4.78K | -23 | -7% |
|
5
Citadel Advisors
Miami,
Florida
| $35K | -$9.98K | -48 | -21% |
|
|
PFO
6
Pathstone Family Office
Englewood,
New Jersey
| $3K | – | – | – |
|
|
U
7
UBS
Zurich,
Switzerland
| $2K | +$2.08K | +10 | New |
|
|
VKH
8
Virtu KCG Holdings
New York
| – | -$7K | -28 | Closed |
|
CPHI Hedge Fund Activity: Q2 2014 in Review
7 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in China Pharma Holdings (CPHI) for Q2 2014, worth a combined $1.17M — down 43% from $2.05M a quarter earlier.
Fund positioning in CPHI was balanced in Q2 2014: 1 fund opened new positions, 1 closed out, 0 added to existing stakes and 4 trimmed.
The largest buyer was UBS, opening a new position worth an estimated $2.08K. The largest seller was Pope Asset Management, cutting an estimated $410K.
- 7 institutional investors held China Pharma Holdings (CPHI) as of Q2 2014, unchanged from Q1 2014.
- Funds reported $1.17M of China Pharma Holdings stock for Q2 2014, down 43% quarter-over-quarter.
- 1 fund opened new China Pharma Holdings positions in Q2 2014 and 1 closed out, a net change of 0 holders.
- The largest China Pharma Holdings buyer in Q2 2014 was UBS, an estimated $2.08K added.
- The largest China Pharma Holdings seller in Q2 2014 was Pope Asset Management, an estimated $410K sold.
Based on aggregated 13F filings for Q2 2014.